UNITED
STATES


SECURITIES
AND EXCHANGE COMMISSION


Washington,
D.C. 20549





FORM
8-K





CURRENT
REPORT


Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934





Date of Report (Date of earliest
event reported):May 13, 2008


CHINDEX
      INTERNATIONAL, INC.(Exact
      Name of Registrant as Specified in
Charter)
 
  DELAWARE
              
              0-24624
              
              13-3097642(State
      of Incorporation)
              
              (Commission
              
              (IRS
      EmployerFile
      Number)
              
              Identification
      No.)
  
 4340
      EAST WEST HIGHWAY, SUITE 1100,
                  BETHESDA,
      MARYLAND
              
              20814(Address
      of Principal Executive Offices)
              
              (Zip
      Code)





Registrant’s
telephone number, including area code:  (301) 215−7777







Check the
appropriate box below if the Form 8−K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:





[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)





[ ]
Soliciting material pursuant to Rule 14a−12 under the Exchange Act (17 CFR
240.14a−12)





[ ]
Pre−commencement communications pursuant to Rule 14d−2(b) under the Exchange Act
(17 CFR 240.14d−2(b))





[ ]
Pre−commencement communications pursuant to Rule 13e−4(c) under the Exchange Act
(17 CFR 240.13e−4(c))







Item
7.01. Regulation FD Disclosure.





On May
13, 2008, Chindex International, Inc. (the “Company”) issued: (i) a press
release announcing a conference call to discuss the Company’s fiscal 2008
year-end and fourth quarter financial results; (ii) a press release announcing
that the Company will present at the Twenty-Ninth Annual Goldman Sachs Global
Healthcare Conference; and (iii) a press release announcing the filing of a
shelf registration, related strategy and guidance for fiscal 2009. A copy of
each of the press releases is attached hereto as Exhibits 99.1, 99.2 and 99.3,
respectively.





The
information contained in Item 7.01 of this Report and the exhibits attached
hereto shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to
the liabilities of that section, and shall not be incorporated by reference into
any registration statement or other document filed under the Securities Act of
1933 or the Exchange Act.





Statements
made in this report relating to plans, strategies, objectives, economic
performance and trends and other statements that are not descriptions of
historical facts may be forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended (the “Securities Act”), and
Section 21E of the Exchange Act. Forward-looking information is inherently
subject to risks and uncertainties, and actual results could differ materially
from those currently anticipated due to a number of factors, which include, but
are not limited to, the factors set forth under the heading “Risk Factors” in
our annual report on Form 10-K for the year ended March 31, 2007, updates and
additions to those “Risk Factors” in our interim reports on Form 10-Q, Forms 8-K
and in other documents filed by us with the Securities and Exchange Commission
from time to time. In particular, forward-looking statements made in this report
are subject to risks and uncertainties such that there can be no assurances
whatsoever: that the shelf registration statement will be declared effective or
that if so will not require further filings with or accelerations by the SEC;
that the healthcare business in China will continue to grow at recent or other
anticipated rates; that any strategic opportunities will become available to the
Company or, if pursued, will prove to be successful; that the shelf registration
statement will provide actual benefits to the Company in achieving any such
opportunities or such success; that any offering under the shelf registration
statement will be consummated without dilution to stockholders; that the
revenues or operating income as a percentage of revenues of the hospital
division will increase in the amounts anticipated if at all; that either Chinese
governmental approval processes regarding our product registrations or U.S. and
German government-backed loan projects will be successfully completed or lead to
profitable product sales; nor that the medical products division will
return to profitability in the current year.Forward-looking statements
may be identified by terms such as “may”, “will”, “should”, “could”, “expects”,
“plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”,
“forecasts”, “potential”, or “continue” or similar terms or the negative of
these terms. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee future results,
levels of activity, performance or achievements. We have no obligation to update
these forward-looking statements.







Item
9.01                      Financial
Statements and Exhibits





(c)         Exhibits





Exhibit
              Number
            Description99.1
            Press Release ofChindex
      International, Inc., dated
      May 13, 200899.2
            Press Release ofChindex
      International, Inc., dated
      May 13, 200899.3
            Press Release ofChindex
      International, Inc., dated
      May 13, 2008










SIGNATURES





Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.





Date:  May
15, 2008




CHINDEX
      INTERNATIONAL, INC.By:
              /s/
      Lawrence PembleName: 
      Lawrence PembleTitle: 
      Chief Financial Officer





INDEX TO
EXHIBITS




Exhibit99.1
              Press Release ofChindex
      International, Inc., dated
      May 13, 200899.2
              Press Release ofChindex
      International, Inc., dated
      May 13, 200899.3
              Press Release ofChindex
      International, Inc., dated
      May 13, 2008